Literature DB >> 33879104

Active behavior of triple-negative breast cancer with adipose tissue invasion: a single center and retrospective review.

Junzo Yamaguchi1, Hiroki Moriuchi2, Takashi Ueda3, Yujo Kawashita3, Takanori Hazeyama3, Masaki Tateishi3, Shigehisa Aoki4, Kazuyoshi Uchihashi5, Mikio Nakamura6.   

Abstract

BACKGROUND: Interactions between adipocyte and breast cancer (BC) cells have yet to be fully elucidated. Here we investigated the prognostic impact of marginal adipose tissue invasion in both luminal breast cancer (HR+/HER2-) and triple-negative breast cancer (TNBC) (HR-/HER2-).
METHODS: A total of 735 patients with early-stage invasive BC (1999-2014) were retrospectively registered. Median length of patient follow-up was 8.9 years. Survival curves were calculated using a Kaplan-Meier cumulative survival plot. The prognostic difference between two groups were assessed by the univariate Cox-proportional hazard regression model.
RESULTS: Patients with adipose tissue invasion (n = 614) had a significantly poorer prognosis than those without adipose tissue invasion (n = 121) in overall survival (OS) (hazard ratio, 2.1; 95% Confidence interval [CI], 1.1 to 4.0; P = 0.025). While a poorer prognosis was observed in TNBC (n = 137) than in luminal BC patients (n = 496) (hazard ratio, 0.45; 95% CI, 0.30 to 0.68, P < 0.001), this aggressive nature of TNBC was noted in node-positive disease (hazard ratio, 0.3; 95% CI, 0.18 to 0.5, P < 0.001) but not in node-negative disease (hazard ratio, 0.78; 95% CI, 0.39 to 1.55, P = 0.472), and also noted in adipose tissue invasion-positive patients (hazard ratio, 0.4; 95% CI, 0.26 to 0.6, P < 0.001) but not in adipose tissue invasion-negative patients (hazard ratio, 0.73; 95% CI, 0.16 to 3.24, P = 0.675). In addition, although patients suffering from TNBC with adipose tissue invasion had a poorer outcome than those without adipose tissue invasion (hazard ratio, 3.63; 95% CI, 1.11 to 11.84; P = 0.033), the difference was not observed in luminal BC (hazard ratio, 1.75; 95% CI, 0.64 to 4.82; P = 0.277).
CONCLUSIONS: Adipose tissue invasion was correlated with poor survival in TNBC. Cancer cell invasion into local fat may be a first step on cancer progression and systemic disease in TNBC.

Entities:  

Keywords:  Adipose tissue invasion; Luminal breast cancer; Patient survival; Triple-negative breast cancer; Tumor microenvironment

Year:  2021        PMID: 33879104     DOI: 10.1186/s12885-021-08147-2

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  21 in total

Review 1.  Triple-negative breast cancer.

Authors:  William D Foulkes; Ian E Smith; Jorge S Reis-Filho
Journal:  N Engl J Med       Date:  2010-11-11       Impact factor: 91.245

2.  Impact of breast cancer subtypes and patterns of metastasis on outcome.

Authors:  Karin Kast; Theresa Link; Katrin Friedrich; Andrea Petzold; Antje Niedostatek; Olaf Schoffer; Carmen Werner; Stefanie J Klug; Andreas Werner; Axel Gatzweiler; Barbara Richter; Gustavo Baretton; Pauline Wimberger
Journal:  Breast Cancer Res Treat       Date:  2015-03-18       Impact factor: 4.872

Review 3.  Accessories to the crime: functions of cells recruited to the tumor microenvironment.

Authors:  Douglas Hanahan; Lisa M Coussens
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

4.  MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer.

Authors:  M Xiao; C Lou; H Xiao; Y Yang; X Cai; C Li; S Jia; Y Huang
Journal:  Br J Surg       Date:  2017-11-08       Impact factor: 6.939

5.  Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b-Mediated Malignant Progression.

Authors:  Manuel Picon-Ruiz; Chendong Pan; Katherine Drews-Elger; Kibeom Jang; Alexandra H Besser; Dekuang Zhao; Cynthia Morata-Tarifa; Minsoon Kim; Tan A Ince; Diana J Azzam; Seth A Wander; Bin Wang; Burcu Ergonul; Ram H Datar; Richard J Cote; Guy A Howard; Dorraya El-Ashry; Pablo Torné-Poyatos; Juan A Marchal; Joyce M Slingerland
Journal:  Cancer Res       Date:  2016-01-07       Impact factor: 12.701

6.  The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.

Authors:  P Dubsky; J C Brase; R Jakesz; M Rudas; C F Singer; R Greil; O Dietze; I Luisser; E Klug; R Sedivy; M Bachner; D Mayr; M Schmidt; M C Gehrmann; C Petry; K E Weber; K Fisch; R Kronenwett; M Gnant; M Filipits
Journal:  Br J Cancer       Date:  2013-10-24       Impact factor: 7.640

7.  Adipocytes promote malignant growth of breast tumours with monocarboxylate transporter 2 expression via β-hydroxybutyrate.

Authors:  Chun-Kai Huang; Po-Hao Chang; Wen-Hung Kuo; Chi-Long Chen; Yung-Ming Jeng; King-Jen Chang; Jin-Yuh Shew; Chun-Mei Hu; Wen-Hwa Lee
Journal:  Nat Commun       Date:  2017-03-10       Impact factor: 14.919

8.  Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.

Authors:  Dennis C Sgroi; Ivana Sestak; Jack Cuzick; Yi Zhang; Catherine A Schnabel; Brock Schroeder; Mark G Erlander; Anita Dunbier; Kally Sidhu; Elena Lopez-Knowles; Paul E Goss; Mitch Dowsett
Journal:  Lancet Oncol       Date:  2013-09-12       Impact factor: 41.316

Review 9.  Tumor-associated stromal cells as key contributors to the tumor microenvironment.

Authors:  Karen M Bussard; Lysette Mutkus; Kristina Stumpf; Candelaria Gomez-Manzano; Frank C Marini
Journal:  Breast Cancer Res       Date:  2016-08-11       Impact factor: 6.466

Review 10.  How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment.

Authors:  Diana P Saraiva; M Guadalupe Cabral; António Jacinto; Sofia Braga
Journal:  ESMO Open       Date:  2017-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.